GTG 9.26% 4.9¢ genetic technologies limited

Covid test by end Q1 2021, page-23

  1. 153 Posts.
    lightbulb Created with Sketch. 14
    I've been a long term shareholder and supporter of GTG over the years, their intellectual property, their potential, etc.

    However, their ability to "continually" miss their own deadlines is out of this world! They don't miss their own deadlines by days or weeks, but more like months and even quarters.

    What's the use of developing a COVID-19 test to assist with determining people's susceptibility of COVID-19 and how it would impact them, potentially helping governments with the prioritisation of giving the vaccines, when you don't get it to market "before" the vaccines are discovered, or approved or even distributed and issued.

    In addition, GTG Management's inability to keep the market informed is ridiculous! They raised a record amount of money off the back of this, diluted shareholders' value even further, only to go quiet for 3 months. The silence is deafening.
 
watchlist Created with Sketch. Add GTG (ASX) to my watchlist
(20min delay)
Last
4.9¢
Change
-0.005(9.26%)
Mkt cap ! $6.478M
Open High Low Value Volume
5.3¢ 5.3¢ 4.8¢ $46.75K 911.8K

Buyers (Bids)

No. Vol. Price($)
1 10000 4.7¢
 

Sellers (Offers)

Price($) Vol. No.
5.2¢ 96858 1
View Market Depth
Last trade - 16.10pm 16/07/2024 (20 minute delay) ?
GTG (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.